Stockreport

BridgeBio Pharma, Inc. Reports Third Quarter 2022 Financial Results and Business Update

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report
PDF - Reported positive preclinical data for its next-generation KRASG12C GTP/GDP dual inhibitor development candidate, BBO-8520, and for its novel PI3Ka:RAS breaker mechani [Read more]